Lung cancer staging now and in the future
Chong-Kin Liam1, Sita Andarini, Pyng Lee
1Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Summary
Accurate lung cancer staging is crucial for effective treatment and prognosis. This involves advanced imaging like CT and PET/CT, alongside minimally invasive sampling, adapted for resource availability in Asian countries.
Area of Science:
- Oncology
- Pulmonology
- Radiology
- Public Health
Background:
- Lung cancer management historically faced a fatalistic outlook.
- Recent advancements in diagnostics, imaging, and treatments offer optimism.
- Accurate staging is critical for determining treatment pathways and patient prognosis.
Purpose of the Study:
- To outline an optimal and resource-appropriate lung cancer staging algorithm for Asian healthcare settings.
- To emphasize the role of pulmonologists in a multidisciplinary approach.
- To advocate for uniform standards of care and tobacco control in Asia.
Main Methods:
- Contrast computed tomography (CT) of the chest and upper abdomen.
- Positron emission tomography/CT (PET/CT) for mediastinal and extrathoracic staging.
- Endosonography-guided needle sampling as an alternative to mediastinoscopy.
- Clinically indicated brain imaging.
Main Results:
- The proposed staging algorithm integrates advanced imaging and minimally invasive techniques.
- Adaptability of staging protocols is essential, considering diverse healthcare resources and economic factors in Asia.
- Pulmonologists are central to lung cancer diagnosis, staging, and management.
Conclusions:
- Optimal lung cancer staging requires a tailored, cost-effective approach considering regional resources.
- Collaboration among respiratory societies is needed to establish uniform care standards.
- Prioritizing tobacco control and cost-effective care delivery is paramount for improving lung cancer outcomes in Asia.
Related Concept Videos
Cancer Survival Analysis
855
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
855
Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K


